celularity.com (CELU) Company Sales Volume
Celularity Inc. ensures stable margins through a diversified network of cryogenic hubs. The company's total sales on the GURU.Markets chart reflect the current 0.02 metric, confirming the efficiency of biomaterial logistics at ultra-low temperatures. High barriers to entry are created by stem cell patents and strict FDA oversight, which protect the business from new entrants.
Analytical breakdowns for Celularity Inc.
- price and consensus price forecast:
- market capitalization details:
- issuer book value statistics:
- debt and solvency information:
- business earnings and investment ratios data:
CELU - Company Net Income|Expected Net Income Celularity Inc.|CELU - P/E Multiple|Market Cap to Projected Earnings Celularity Corp|CELU - Price/Earnings to Growth Multiple|Enterprise Value to Operating Income Before Depreciation Ratio Celularity Inc.|CELU - Operating profit before deduction of amortization|Net earnings per one share for the last twelve months Celularity|CELU - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months celularity.com|CELU - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Celularity Inc.
- company sales and revenue statistics:
General company analysis:CELU, celularity.com
The market value of Celularity Inc. (CELU) correlates directly with the efficiency of its technological potential realization. The company's trading revenue aggregates all cash inflows from biomaterial sales, reflecting actual demand for cellular products. This data stream confirms the successful commercial adaptation of the platform through medical and retail distribution channels. Investors should view this indicator as the primary marker of management's ability to monetize scientific developments.
Analysis of competing companies
Revenue and Sales Volume argenx BVBA|Company Revenue BioNTech SE (BNTX)|Abivax SA - Company Sales Volume|Revenue and Sales Volume ADMA (ADMA Biologics, Inc.)|Protagonist Therapeutics, Inc. (PTGX) - Company Total Revenue|Immunovant Corp - Revenue and Sales Volume|Kiniksa Corp (KNSA) - Company Sales|GRFS: Revenue and Sales Volume|Company Total Revenue adaptivebiotech.com (ADPT)|Company Revenue Celldex Therapeutics, Inc.|Company Revenue AUPH|Company Sales BCRX (BioCryst Pharmaceuticals Inc)|Revenue and Sales Volume Vera Corp (VERA)|Company Revenue Dianthus Therapeutics DNTH|pharvaris.com - Company Revenue|AbCellera - Revenue and Sales Volume|TRML - Revenue and Sales Volume|Intrexon (PGEN) - Company Revenue|Pharming Corp - Company Sales Revenue|NKTR (Nektar Therapeutics) - Revenue and Sales Volume|upstreambio.com (UPB) - Company Gross Revenue|Company Sales ZBIO (Zenas Biopharma)|Company Total Sales IMNM|Gossamer Corp - Company Sales|KalVista Corp (KALV) - Company Total Revenue|SEPN: Company Sales|Company Sales Revenue PVLA (pieris.com)|SVRA: Revenue and Sales Volume|RIGL - Company Gross Revenue|Company Revenue AnaptysBio Corp|Company Sales Volume ATXS (Astria Corp)|Revenue and Sales Volume ENGN|Company Sales rapt.com RAPT|Aerovate Therapeutics - Company Sales|Company Gross Revenue Aclaris Therapeutics Inc. (ACRS)|Kyverna - Revenue and Sales Volume|Tiziana Life Sciences, Ltd. (TLSA) - Company Sales|CABA: Revenue and Sales Volume|Company Total Revenue ventyxbio.com (VTYX)|Company Revenue Theratechnologies|Company Revenue AVTX|Company Sales ELDN (Eledon)|Revenue and Sales Volume Agenus, Inc (AGEN)|Company Revenue Climb Bio Inc CLYM|ZURA (zurabio.com) - Company Annual Revenue|aTyr Pharma - Revenue and Sales Volume|Company Sales Revenue ADAG (Adagene)|IMA: Revenue and Sales Volume|Shattuck Labs (STTK) - Revenue and Sales Volume|Company Revenue Equillium Inc|CNTB: Company Sales Revenue|Company Revenue Immunic, Inc. (IMUX)|Company Sales atarabio.com ATRA|Revenue and Sales Volume IFRX (InflaRx)|Revenue and Sales Volume X4 Pharmaceuticals, Inc XFOR|ACET: Company Sales|Company Sales Revenue INMB (inmunebio.com)|BRNS: Revenue and Sales Volume|KZR - Company Gross Revenue|Company Revenue SAB Biotherapeutics, Inc|Company Sales Akari Therapeutics, Plc (AKTX)|Company Revenue Enlivex Therapeutics (ENLV)|Company Sales q32bio.com QTTB|GeoVax - Company Sales|Revenue and Sales Volume Edesa Biotech Inc EDSA|IBIO - Company Revenue|CARM (Carisma Therapeutics) - Company Sales Volume|XTLB: Revenue and Sales Volume|Company Total Revenue Bolt Biotherapeutics, Inc. (BOLT)|HCWB (HCW Biologics, Inc.) - Revenue and Sales Volume|Company Sales Aptevo (APVO)|Revenue and Sales Volume AIM|ADTX - Company Total Revenue|Company Revenue GRI Bio, Inc. GRI|xortx.com - Company Revenue|HIND: Company Sales|REVB - Revenue and Sales Volume|Indaptus (INDP) - Company Revenue|SCNI (BiondVax Pharmaceuticals) - Company Revenue|CALI (CalciMedica Inc) - Revenue and Sales Volume|Revenue and Sales Volume Affimed Therapeutics|Company Revenue Allakos Inc. (ALLK)|HOOK (hookipapharma.com) - Company Sales Revenue|Revenue and Sales Volume IGMS (IGM Biosciences)|Company Gross Revenue iTeos Pharma (ITOS)|OCEA: Company Sales|tcbiopharm.com - Company Total Sales|THRD (Third Harmonic Bio, Inc.) - Company Sales
